Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cong Thanh Nguyen has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Kazumasa Ogasawara

    Division of Pathgenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan

    5 shared publications
  • Yasushi Itoh

    Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan; Central Research Laboratory, Shiga University of Medical Science, Otsu, Japan

    5 shared publications
  • Hirohito Ishigaki

    Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Japan

    4 shared publications
  • Hiroshi Kida

    Global Institution for Collaborative Research and Education, Hokkaido University, Sapporo, Hokkaido, Japan

    4 shared publications
  • Misako Nakayama

    Division of Pathogenesis and Disease Regulation, Department of Pathology Shiga University of Medical Science Otsu Japan

    4 shared publications
  • Hirohito Ishigaki

    Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science, Otsu, Shiga, Japan

    3 shared publications

Latest Publications

  • Open Access

    Altered NAD metabolism during CNS viral infection and modest immunometabolic effects of NMN in different contexts

    by Cong Thanh Nguyen, Fumitaka Sato, Seiichi Omura, Ijaz Ahmad, Sandesh Rimal, Ah-Mee Park, Reona Shiro, Alfredo A. Hinay, Ryoichi Sugisawa, Satoshi Miyanaga, et al.

    Viral infection of the central nervous system (CNS) is increasingly linked to neurodegenerative disease, yet the metabolic programs that shape antiviral immunity and neuroinflammation remain poorly defined. Nicotinamide adenine dinucleotide (NAD) regulates mitochondrial function and immune signaling, and supplementation with its precursor nicotinamide mononucleotide (NMN) has been proposed as a therapeutic strategy; its impact during active CNS viral infection remains unclear. Here, we performed an exploratory study to characterize NAD metabolism and immunometabolic responses across both acute and chronic CNS viral infection using Theiler’s murine encephalomyelitis virus (TMEV), a model of virus-induced neurodegeneration. Integrated transcriptomic, metabolomic, and histopathological analyses revealed stage-dependent remodeling of NAD-related pathways during TMEV infection. Chronic infection was characterized by marked induction of selected NAD-related genes, accompanied by accumulation of L-kynurenine and MNA. In vitro, NMN supplementation modestly increased NAD levels while downregulating a subset of inflammatory transcripts under basal conditions, suggesting subtle shifts in basal immunometabolic states. During infection, NMN produced context-dependent effects on inflammatory responses and viral replication, although these effects were generally modest. In vivo , NMN increased CNS and systemic MNA levels in selected infection contexts and was associated with an IgG1-skewed humoral immune response but did not substantially alter viral persistence or neuropathology. Collectively, these findings demonstrate that CNS viral infection is accompanied by dynamic remodeling of NAD-related pathways, particularly in chronic infection. NMN supplementation produces modest, context-dependent effects on metabolic and immune responses, with limited impact on overall disease outcomes.

  • Open Access

    The Safety of Alcaligenes Lipid A in a Virus-Induced Immune Disease Model Associated with IgA, Th17 Cells, and Microbiota

    by Ijaz Ahmad, Seiichi Omura, Sundar Khadka, Fumitaka Sato, Ah-Mee Park, Cong Thanh Nguyen, Sandesh Rimal, Koichi Fukase, Atsushi Shimoyama, Ikuo Tsunoda

    Lipid A is a component of lipopolysaccharide (LPS) of Gram-negative bacteria. Previously, we demonstrated that synthesized lipid A derived from Alcaligenes faecalis (ALA) could enhance antigen-specific immunoglobulin (Ig) A and T helper (Th) 17 responses, when ALA was co-administered experimentally with an antigen as a vaccine adjuvant. This raised concerns about the safety of the ALA usage, since IgA and Th17 responses have been suggested to play a pathogenic role in several immune-mediated diseases, including multiple sclerosis (MS). We investigated whether ALA administrations could exacerbate an animal model of MS, Theiler’s murine encephalomyelitis virus (TMEV) infection. TMEV-infected SJL/J mice were administered ALA at various time points, and their neurological signs were observed for 7 weeks. We found that ALA administrations did not exacerbate TMEV-induced inflammatory disease or viral persistence in the central nervous system (CNS), clinically or histologically. Furthermore, ALA administrations did not enhance TMEV-specific humoral and cellular responses, including IgA and Th17 responses. On the other hand, principal component analysis (PCA) of the fecal, not the ileal, samples showed significant changes in the microbiota, characterized by increases in the relative abundance of bacteria belonging to the phylum Bacteroidota, including the genera Alistipes and Bacteroides. Therefore, ALA injections could be safe for use in immune-mediated diseases, whose immunopathology has been associated with IgA and Th17 responses.


  • MHC‐DRB alleles with amino acids Val11, Phe13, and the shared epitopes promote collagen‐induced arthritis and a rapid IgG1 response in Filipino cynomolgus macaques

    by Hirohito Ishigaki, Sayaka Ito, Takako Sasamura, Hideaki Ishida, Misako Nakayama, Cong Thanh Nguyen, Takaaki Kinoshita, Shingo Suzuki, Chizuru Iwatani, Hideaki Tsuchiya, et al.

    Macaques are useful animal models for studying the pathogenesis of rheumatoid arthritis (RA) and the development of anti‐rheumatic drugs. The purpose of this study was to identify the major histocompatibility complex (MHC) polymorphisms associated with the pathology of collagen‐induced arthritis (CIA) and anti‐collagen IgG induction in a cynomolgus macaque model, as MHC polymorphisms affect the onset of CIA in other animal models. Nine female Filipino cynomolgus macaques were immunized with bovine type II collagen (b‐CII) to induce CIA, which was diagnosed clinically by scoring the symptoms of joint swelling over 9 weeks. MHC polymorphisms and anti‐b‐CII antibody titers were compared between symptomatic and asymptomatic macaques. Four of 9 (44%) macaques were defined as the CIA‐affected group. Anti‐b‐CII IgG in the affected group increased in titer approximately 3 weeks earlier compared with the asymptomatic group. The mean plasma IgG1 titer in the CIA‐affected group was significantly higher (p < 0.05) than that of the asymptomatic group. Furthermore, the cynomolgus macaque MHC (Mafa)‐DRB1*10:05 or Mafa‐DRB1*10:07 alleles, which contain the well‐documented RA‐susceptibility five amino acid sequence known as the shared epitope (SE) in positions 70 to 74, with valine at position 11 (Val11, V11) and phenylalanine at position 13 (Phe13, F13), were detected in the affected group. In contrast, no MHC polymorphisms specific to the asymptomatic group were identified. In conclusion, the presence of V11 and F13 along with SE in the MHC‐DRB1 alleles seems essential for the production of IgG1 and the rapid induction of severe CIA in female Filipino cynomolgus macaques.


  • Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells

    by Masashi Shingai, Naoki Nomura, Toshiki Sekiya, Marumi Ohno, Daisuke Fujikura, Chimuka Handabile, Ryosuke Omori, Yuki Ohara, Tomohiro Nishimura, Masafumi Endo, et al.


  • Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques

    by Saori Suzuki, Cong Thanh Nguyen, Ayako Ogata-Nakahara, Akihiro Shibata, Hiroyuki Osaka, Hirohito Ishigaki, Masatoshi Okamatsu, Yoshihiro Sakoda, Hiroshi Kida, Kazumasa Ogasawara, et al.

    H7N9 highly pathogenic avian influenza virus (HPAIV) infection in a human was first reported in 2017. A/duck/Japan/AQ-HE29-22/2017 (H7N9) (Dk/HE29-22), found in imported duck meat at an airport in Japan, possesses a hemagglutinin with a multibasic cleavage site, indicating high pathogenicity in chickens, as in the case of other H7 HPAIVs.


  • Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques

    by Hirohito Ishigaki, Misako Nakayama, Yoshinori Kitagawa, Cong Thanh Nguyen, Kaori Hayashi, Masanori Shiohara, Bin Gotoh, Yasushi Itoh


  • Immune profiling of influenza‐specific B‐ and T‐cell responses in macaques using flow cytometry‐based assays

    by Marios Koutsakos, Toshiki Sekiya, Brendon Y. Chua, Thi Hoang Oanh Nguyen, Adam K. Wheatley, Jennifer A Juno, Marumi Ohno, Naoki Nomura, Yuki Ohara, Tomohiro Nishimura, et al.

    Influenza remains a significant global public health burden, despite substantial annual vaccination efforts against circulating virus strains. As a result, novel vaccine approaches are needed to generate long‐lasting and universal broadly cross‐reactive immunity against distinct influenza virus strains and subtypes. Several new vaccine candidates are currently under development and/or in clinical trials. The successful development of new vaccines requires testing in animal models, other than mice, which capture the complexity of the human immune system. Importantly, following vaccination or challenge, the assessment of adaptive immunity at the antigen‐specific level is particularly informative. In this study, using peripheral blood mononuclear cells (PBMCs) from cynomolgus macaques, we describe detection methods and in‐depth analyses of influenza virus‐specific B cells by recombinant hemagglutinin probes and flow cytometry, as well as the detection of influenza virus‐specific CD8+ and CD4+ T cells by stimulation with live influenza A virus and intracellular cytokine staining. We highlight the potential of these assays to be used with PBMCs from other macaque species, including rhesus macaques, pigtail macaques and African green monkeys. We also demonstrate the use of a human cytometric bead array kit in detecting inflammatory cytokines and chemokines from cynomolgus macaques to assess cytokine/chemokine milieu. Overall, the detection of influenza virus‐specific B and T cells, together with inflammatory responses, as described in our study, provides useful insights for evaluating novel influenza vaccines. Our data deciphering immune responses toward influenza viruses can be also adapted to understanding immunity to other infections or vaccination approaches in macaque models.


  • Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model

    by Cong Thanh Nguyen, Saori Suzuki, Yasushi Itoh, Hirohito Ishigaki, Misako Nakayama, Kaori Hayashi, Keita Matsuno, Masatoshi Okamatsu, Yoshihiro Sakoda, Hiroshi Kida, et al.

    Attention has been paid to H5N6 highly pathogenic avian influenza virus (HPAIV) because of its heavy burden on the poultry industry and human mortality. Since an influenza A virus carrying N6 neuraminidase (NA) has never spread in humans, the potential for H5N6 HPAIV to cause disease in humans and the efficacy of antiviral drugs against the virus need to be urgently assessed. We used nonhuman primates to elucidate the pathogenesis of H5N6 HPAIV as well as to determine the efficacy of antiviral drugs against the virus.


  • Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution

    by Saori Suzuki, Shintaro Shichinohe, Yasushi Itoh, Misako Nakayama, Hirohito Ishigaki, Yuya Mori, Ayako Ogata-Nakahara, Cong Thanh Nguyen, Masatoshi Okamatsu, Yoshihiro Sakoda, et al.